bioresorbable scaffold

DEVICE2 trials

Sponsors

Biotronik AG, Xuzhou Third People's Hospital

Conditions

Coronary Artery DiseaseCoronary Artery Disease(CAD)de Novo Coronary Lesions

Unknown Phase

Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold

SuspendedNCT02916485

Biotronik AGCoronary Artery Disease

Start: 2017-06-30End: 2018-09-30Target: 100Updated: 2017-06-14

The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT

Not yet recruitingNCT07162792

Xuzhou Third People's HospitalCoronary Artery Disease(CAD), de Novo Coronary Lesions

Start: 2025-10-23End: 2028-12-30Target: 150Updated: 2025-09-09